Go Pro
NYSE:NVST

Envista (NVST) Stock Price, News & Analysis

Envista logo
$26.13 -0.09 (-0.34%)
Closing price 07/14/2026 03:59 PM Eastern
Extended Trading
$25.80 -0.33 (-1.26%)
As of 04:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Envista Stock (NYSE:NVST)

Advanced

Key Stats

Today's Range
$25.52
$26.24
50-Day Range
$22.38
$27.59
52-Week Range
$18.77
$30.42
Volume
2.38 million shs
Average Volume
2.54 million shs
Market Capitalization
$4.25 billion
P/E Ratio
63.74
Dividend Yield
N/A
Price Target
$28.54
Consensus Rating
Hold

Company Overview

Envista Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

NVST MarketRank™: 

Envista scored higher than 49% of companies evaluated by MarketBeat, and ranked 313th out of 853 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Envista has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on no strong buy ratings, 6 buy ratings, 10 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Envista is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Envista has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Envista's stock forecast and price target.
  • Earnings Growth

    Earnings for Envista are expected to grow by 9.15% in the coming year, from $1.42 to $1.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Envista is 63.74, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 45.97.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Envista is 63.74, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.01.

  • Price to Earnings Growth Ratio

    Envista has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Envista has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Envista's valuation and earnings.
  • Percentage of Shares Shorted

    6.11% of the float of Envista has been sold short.
  • Short Interest Ratio / Days to Cover

    Envista has a short interest ratio ("days to cover") of 3.62, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Envista has recently decreased by 18.73%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Envista does not currently pay a dividend.

  • Dividend Growth

    Envista does not have a long track record of dividend growth.

  • News Sentiment

    Envista has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Envista this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for NVST on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Envista insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.99% of the stock of Envista is held by insiders.

  • Percentage Held by Institutions

    Envista has minimal institutional ownership at this time.

  • Read more about Envista's insider trading history.
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVST Stock News Headlines

A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More Headlines

NVST Stock Analysis - Frequently Asked Questions

Envista's stock was trading at $21.72 at the beginning of the year. Since then, NVST stock has increased by 20.3% and is now trading at $26.1310.

Envista Holdings Corporation (NYSE:NVST) released its earnings results on Wednesday, May, 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. The business's quarterly revenue was up 14.4% compared to the same quarter last year.
Read the conference call transcript
.

Envista (NVST) raised $602 million in an IPO on Wednesday, September 18th 2019. The company issued 26,768,000 shares at a price of $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Envista's top institutional shareholders include Oliver Luxxe Assets LLC (0.05%), Wedge Capital Management L L P NC (0.02%), Versant Capital Management Inc (0.01%) and Legacy Wealth Asset Management LLC. Insiders that own company stock include Amir Aghdaei, Eric Conley, Mark E Nance, Mischa Reis, Eric D Hammes and Stephen Keller.
View institutional ownership trends
.

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Envista investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), The RMR Group (RMR) and AUO (AUOTY).

Company Calendar

Last Earnings
5/06/2026
Today
7/15/2026
Next Earnings (Estimated)
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:NVST
CIK
1757073
Employees
12,000
Year Founded
2018

Price Target and Rating

High Price Target
$35.00
Low Price Target
$21.00
Potential Upside/Downside
+9.2%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
16 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.41
Trailing P/E Ratio
63.74
Forward P/E Ratio
18.40
P/E Growth
1.49
Net Income
$47 million
Net Margins
2.41%
Pretax Margin
7.14%
Return on Equity
7.11%
Return on Assets
3.91%

Debt

Debt-to-Equity Ratio
0.47
Current Ratio
2.44
Quick Ratio
2.06

Sales & Book Value

Annual Sales
$2.72 billion
Price / Sales
1.56
Cash Flow
$2.16 per share
Price / Cash Flow
12.08
Book Value
$18.89 per share
Price / Book
1.38

Miscellaneous

Outstanding Shares
162,730,000
Free Float
161,117,000
Market Cap
$4.25 billion
Optionable
Optionable
Beta
0.86

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NYSE:NVST) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners